Search

September 18, 2015 - This Advanced Training Statement addresses the added competencies required of subsubspecialists in CCEP for diagnosis and management of patients with cardiac arrhythmias and conduction disturbances at a high level of skill. It is intended to complement the basic training in cardiac electrophysiology (EP) required of all trainees during the standard 3-year cardiovascular fellowship.

May 12, 2017 — The 2017 Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation represents a complete rewrite of the 2012 HRS/EHRA/ECAS Expert Consensus Statement. This document provides updated definitions, mechanisms, and rationale for atrial fibrillation (AF) ablation and consensus recommendations concerning indications, strategies, techniques, and endpoints, technology and tools, and follow-up considerations for AF ablation. The document also provides definitions to be used in clinical trials and recommendations that will impact clinical trial design. The document was developed in joint partnership with EHRA, ECAS, APHRS, and SOLAECE. Collaborators on the document include STS, ACC, AHA, CHRS, JHRS, and SOBRAC. 

This document features a clinician summary  (an educational derivative product of the full document), a slide set  (an educational tool for electrophysiologists, cardiologists, and other licensed health care practitioners), an Executive Summary,  and an interview with Hugh Calkins, MD, FHRS, by HeartRhythm Online Editor Daniel P. Morin, MD, MPH, FHRS. 

The Catheter and Surgical Ablation of Atrial Fibrillation pocket card, a valuable educational reference tool created in partnership with Guideline Central, is available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com  to access the pocket card.

May 11, 2017 — The 2017 HRS Expert Consensus Statement on Magnetic Resonance Imaging and Radiation Exposure in Patients with Cardiovascular Implantable Electronic Devices presents recommendations intended to help health care providers of various backgrounds involved in the care of adult and pediatric patients with cardiovascular implantable electronic devices (CIEDs) who are to undergo magnetic resonance imaging, computed tomography, and/or radiation treatment. The document also addresses the safety of employees with CIEDs who may come into an MRI environment.

This document features a clinician summary  — an educational derivative product of the full document.

The MRI and Radiation Exposure in Patients with CIEDs pocket card, a valuable educational reference tool created in partnership with Guideline Central, is available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com to access the pocket card. 

May 8, 2017 — Ambulatory ECG (AECG) is commonly used in a variety of clinical contexts to detect cardiac arrhythmias and/or arrhythmia patterns that are not readily obtained from the standard ECG. Accurate and timely characterization of arrhythmias is crucial to direct therapies that can have an important impact on diagnosis, prognosis, or patient symptom status. The rhythm information derived from the large variety of AECG recording systems can often lead to appropriate and patient-specific medical and interventional management. This document provides background and framework from which to apply AECG techniques in clinical practice, as well as clinical research.

The Heart Rhythm Society (HRS) has been developing clinical practice documents in collaboration and partnership with other professional medical societies since 1996. The HRS formed a Scientific and Clinical Documents Committee (SCDC) with the sole purpose of managing the development of these documents from conception through publication. The SCDC oversees the process for developing clinical practice documents, with input and approval from the HRS Executive Committee and the Board of Trustees. As of September 2017, the HRS has produced more than 80 publications with other professional organizations. The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements. 

September 19, 2016 - Drug therapy with beta blockers represents the therapeutic mainstay for both LQTS and CPVT. Our goal is to help clinicians understand the importance of beta blocker therapy in these two genetic disorders, as well as to provide clinical guidance on the choice of agents. Nadolol, when available, has been the preferred beta blocker utilized by the largest LQTS/CPVT specialty centers throughout the world for the past 25 years.